220 related articles for article (PubMed ID: 34975345)
1. The Advance and Correlation of
Yu K; Wang Y
Pathol Oncol Res; 2021; 27():1609906. PubMed ID: 34975345
[TBL] [Abstract][Full Text] [Related]
2. Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer.
Agusti N; Kanbergs A; Nitecki R
Gynecol Oncol; 2024 Jun; 185():121-127. PubMed ID: 38402734
[TBL] [Abstract][Full Text] [Related]
3. Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification.
Cavaliere AF; Perelli F; Zaami S; D'Indinosante M; Turrini I; Giusti M; Gullo G; Vizzielli G; Mattei A; Scambia G; Vidiri A; Signore F
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830129
[TBL] [Abstract][Full Text] [Related]
4. The relationship between
Çintesun FNİ; Kerimoğlu ÖS; Çintesun E; Nergiz S; Acar H; Çelik Ç
J Obstet Gynaecol; 2020 Oct; 40(7):988-993. PubMed ID: 31790621
[TBL] [Abstract][Full Text] [Related]
5. [KRAS mutations analysis in mucinous epithelial lesions of the endometrium].
Zheng XZ; Zhan Y; Ma JH; Xu HW; Zhi WX; Chen TB; Qin XY; Wang P; Zhang LH; Gu YC; Jin YL; Zhu L; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):687-690. PubMed ID: 30220122
[No Abstract] [Full Text] [Related]
6. A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium.
Kolin DL; Costigan DC; Dong F; Nucci MR; Howitt BE
Am J Surg Pathol; 2019 Mar; 43(3):389-398. PubMed ID: 30489318
[TBL] [Abstract][Full Text] [Related]
7. Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
Chung YS; Woo HY; Lee JY; Park E; Nam EJ; Kim S; Kim SW; Kim YT
Am J Obstet Gynecol; 2021 Apr; 224(4):370.e1-370.e13. PubMed ID: 33039397
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Characteristics and
Sung JY; Jung YY; Kim HS
Anticancer Res; 2018 May; 38(5):2779-2786. PubMed ID: 29715099
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.
Dobrzycka B; Terlikowski SJ; Mazurek A; Kowalczuk O; Niklińska W; Chyczewski L; Kulikowski M
Folia Histochem Cytobiol; 2009; 47(1):65-8. PubMed ID: 19419940
[TBL] [Abstract][Full Text] [Related]
10. Molecular approaches for classifying endometrial carcinoma.
Piulats JM; Guerra E; Gil-Martín M; Roman-Canal B; Gatius S; Sanz-Pamplona R; Velasco A; Vidal A; Matias-Guiu X
Gynecol Oncol; 2017 Apr; 145(1):200-207. PubMed ID: 28040204
[TBL] [Abstract][Full Text] [Related]
11. Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial Preservation?
Dellino M; Cerbone M; Laganà AS; Vitagliano A; Vimercati A; Marinaccio M; Baldini GM; Malvasi A; Cicinelli E; Damiani GR; Cazzato G; Cascardi E
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298731
[TBL] [Abstract][Full Text] [Related]
12. The Role of KRAS in Endometrial Cancer: A Mini-Review.
Sideris M; Emin EI; Abdullah Z; Hanrahan J; Stefatou KM; Sevas V; Emin E; Hollingworth T; Odejinmi F; Papagrigoriadis S; Vimplis S; Willmott F
Anticancer Res; 2019 Feb; 39(2):533-539. PubMed ID: 30711927
[TBL] [Abstract][Full Text] [Related]
13. Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.
Pappa KI; Choleza M; Markaki S; Giannikaki E; Kyroudi A; Vlachos G; Voulgaris Z; Anagnou NP
Gynecol Oncol; 2006 Mar; 100(3):596-600. PubMed ID: 16256179
[TBL] [Abstract][Full Text] [Related]
14. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia.
Zauber P; Denehy TR; Taylor RR; Ongcapin EH; Marotta S; Sabbath-Solitare M
Int J Gynecol Cancer; 2015 Jun; 25(5):863-8. PubMed ID: 25768080
[TBL] [Abstract][Full Text] [Related]
15. Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer.
Kawaguchi M; Yanokura M; Banno K; Kobayashi Y; Kuwabara Y; Kobayashi M; Nomura H; Hirasawa A; Susumu N; Aoki D
Int J Oncol; 2009 Jun; 34(6):1541-7. PubMed ID: 19424571
[TBL] [Abstract][Full Text] [Related]
16. Fertility preserving management of early endometrial cancer in a patient cohort at the department of women's health at the university of Tuebingen.
Andress J; Pasternak J; Walter C; Kommoss S; Krämer B; Hartkopf A; Brucker SY; Schönfisch B; Steinmacher S
Arch Gynecol Obstet; 2021 Jul; 304(1):215-221. PubMed ID: 33606091
[TBL] [Abstract][Full Text] [Related]
17. KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.
Birkeland E; Wik E; Mjøs S; Hoivik EA; Trovik J; Werner HM; Kusonmano K; Petersen K; Raeder MB; Holst F; Øyan AM; Kalland KH; Akslen LA; Simon R; Krakstad C; Salvesen HB
Br J Cancer; 2012 Dec; 107(12):1997-2004. PubMed ID: 23099803
[TBL] [Abstract][Full Text] [Related]
18. [Fertility-sparing management of endometrial cancer and atypical hyperplasia].
Gonthier C; Trefoux-Bourdet A; Luton D; Koskas M
Gynecol Obstet Fertil Senol; 2017 Feb; 45(2):112-118. PubMed ID: 28368791
[TBL] [Abstract][Full Text] [Related]
19. Updates on Conservative Management of Endometrial Cancer.
Corzo C; Barrientos Santillan N; Westin SN; Ramirez PT
J Minim Invasive Gynecol; 2018 Feb; 25(2):308-313. PubMed ID: 28782618
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of K-ras mutation in endometrial "surface epithelial changes" and their associated endometrial adenocarcinoma.
Xiong J; He M; Hansen K; Jackson CL; Breese V; Quddus MR; Sung CJ; Lomme MM; Lawrence WD
Gynecol Oncol; 2016 Jul; 142(1):163-168. PubMed ID: 27154241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]